How Can Targeting Biological Signals Improve Cancer Treatment?
Understanding the complex network of biological signals in cancer has led to the development of targeted therapies. For example, monoclonal antibodies can specifically target growth factor receptors, while small molecule inhibitors can block signaling pathways like PI3K/AKT or MAPK. Immunotherapies, such as checkpoint inhibitors, aim to modulate immune signals to enhance the body's natural ability to fight cancer. These approaches have shown promising results in various cancer types.
